Department of Medical Microbiology and Immunology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
McArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
Breast Cancer Res. 2018 Sep 12;20(1):111. doi: 10.1186/s13058-018-1036-5.
Antimicrobial T cells play key roles in the disease progression of cancers arising in mucosal epithelial tissues, such as the colon. However, little is known about microbe-reactive T cells within human breast ducts and whether these impact breast carcinogenesis.
Epithelial ducts were isolated from primary human breast tissue samples, and the associated T lymphocytes were characterized using flow cytometric analysis. Functional assays were performed to determine T-cell cytokine secretion in response to bacterially treated human breast carcinoma cells.
We show that human breast epithelial ducts contain mucosal associated invariant T (MAIT) cells, an innate T-cell population that recognizes specific bacterial metabolites presented by nonclassical MR1 antigen-presenting molecules. The MAIT cell population from breast ducts resembled that of peripheral blood in its innate lymphocyte phenotype (i.e., CD161, PLZF, and interleukin [IL]-18 receptor coexpression), but the breast duct MAIT cell population had a distinct T-cell receptor Vβ use profile and was markedly enriched for IL-17-producing cells compared with blood MAIT cells. Breast carcinoma cells that had been exposed to Escherichia coli activated MAIT cells in an MR1-dependent manner. However, whereas phorbol 12-myristate 13-acetate/ionomycin stimulation induced the production of both interferon-γ and IL-17 by breast duct MAIT cells, bacterially exposed breast carcinoma cells elicited a strongly IL-17-biased response. Breast carcinoma cells also showed upregulated expression of natural killer group 2 member D (NKG2D) ligands compared with primary breast epithelial cells, and the NKG2D receptor contributed to MAIT cell activation by the carcinoma cells.
These results demonstrate that MAIT cells from human breast ducts mediate a selective T-helper 17 cell response to human breast carcinoma cells that were exposed to E. coli. Thus, cues from the breast microbiome and the expression of stress-associated ligands by neoplastic breast duct epithelial cells may shape MAIT cell responses during breast carcinogenesis.
抗菌 T 细胞在黏膜上皮组织(如结肠)起源的癌症的疾病进展中发挥关键作用。然而,人们对人类乳腺导管内的微生物反应性 T 细胞知之甚少,也不知道这些细胞是否会影响乳腺癌的发生。
从原发性人乳腺组织样本中分离出上皮导管,并使用流式细胞术分析对相关 T 淋巴细胞进行特征描述。进行功能测定以确定 T 细胞在响应经细菌处理的人乳腺癌细胞时细胞因子的分泌情况。
我们表明,人乳腺上皮导管中含有黏膜相关不变 T(MAIT)细胞,这是一种先天 T 细胞群体,可识别由非经典 MR1 抗原呈递分子呈递的特定细菌代谢产物。乳腺导管中的 MAIT 细胞群体在其先天淋巴细胞表型(即 CD161、PLZF 和白细胞介素[IL]-18 受体共表达)方面与外周血相似,但乳腺导管 MAIT 细胞群体的 T 细胞受体 Vβ 使用谱明显不同,与血液 MAIT 细胞相比,IL-17 产生细胞明显丰富。用大肠杆菌暴露的乳腺癌细胞以 MR1 依赖的方式激活 MAIT 细胞。然而,尽管佛波醇 12-肉豆蔻酸 13-乙酸盐/离子霉素刺激诱导乳腺导管 MAIT 细胞产生干扰素-γ和 IL-17,但经细菌暴露的乳腺癌细胞引发强烈的 IL-17 偏向反应。与原发性乳腺上皮细胞相比,乳腺癌细胞还显示出自然杀伤组 2 成员 D(NKG2D)配体的上调表达,并且 NKG2D 受体有助于 MAIT 细胞被癌细胞激活。
这些结果表明,暴露于大肠杆菌的人乳腺癌细胞中,来自人乳腺导管的 MAIT 细胞介导对人乳腺癌细胞的选择性 Th17 细胞反应。因此,乳腺微生物组的线索和肿瘤性乳腺导管上皮细胞应激相关配体的表达可能在乳腺癌发生过程中塑造 MAIT 细胞反应。